These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22299644)

  • 21. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
    Dhillon S; Keating GM
    Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive liquid chromatographic/tandem mass spectrometric method for the determination of beclomethasone dipropionate and its metabolites in equine plasma and urine.
    Guan F; Uboh C; Soma L; Hess A; Luo Y; Tsang DS
    J Mass Spectrom; 2003 Aug; 38(8):823-38. PubMed ID: 12938103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosols.
    Holz O; Zühlke I; Einhaus M; Welker L; Kanniess F; Branscheid D; Nakashima M; Harrison LI; Jörres RA; Richter K; Magnussen H
    Pulm Pharmacol Ther; 2004; 17(4):233-8. PubMed ID: 15219268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic profile of beclometasone dipropionate/formoterol fumarate administered through a novel dry-powder inhaler in Chinese healthy volunteers.
    Luo Z; Lucci G; Santoro L; Topole E; Mariotti F
    Pulm Pharmacol Ther; 2022 Jun; 73-74():102129. PubMed ID: 35525480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model.
    Freiwald M; Valotis A; Kirschbaum A; McClellan M; Mürdter T; Fritz P; Friedel G; Thomas M; Högger P
    Respir Res; 2005 Feb; 6(1):21. PubMed ID: 15727687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma.
    Grzelewska-Rzymowska I; Kroczynska-Bednarek J; Zarkovic J
    Respir Med; 2003 Feb; 97 Suppl B():S21-6. PubMed ID: 12593524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
    Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.
    Singh D; van den Berg F; Leaker B; Corradi M; Jabbal S; Collarini S; Mongelli V; Santoro L; Piccinno A; Biondaro S; Lipworth B
    Br J Clin Pharmacol; 2019 Apr; 85(4):729-736. PubMed ID: 30586199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.
    Chawes BL; Govoni M; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilsson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Piccinno A; Sergio F; Ciurlia G; Poli G; Acerbi D; Singh D; Bisgaard H
    Respir Med; 2014 Aug; 108(8):1108-16. PubMed ID: 24993817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.
    Govoni M; Piccinno A; Lucci G; Poli G; Acerbi D; Baronio R; Singh D; Kuna P; Chawes BL; Bisgaard H
    Pulm Pharmacol Ther; 2015 Feb; 30():102-9. PubMed ID: 24746942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer.
    Newman SP; Pitcairn GR; Adkin DA; Vidgren MT; Silvasti M
    J Aerosol Med; 2001; 14(2):217-25. PubMed ID: 11681653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study).
    Singh D; Schröder-Babo W; Cohuet G; Muraro A; Bonnet-Gonod F; Petruzzelli S; Hoffmann M; Siergiejko Z;
    Respir Med; 2016 May; 114():84-90. PubMed ID: 27109816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children.
    Chawes BL; Piccinno A; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Sergio F; Ciurlia G; Poli G; Acerbi D; Bisgaard H
    Br J Clin Pharmacol; 2013 Apr; 75(4):1081-8. PubMed ID: 22978252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler
    Virchow JC; Poli G; Herpich C; Kietzig C; Ehlich H; Braeutigam D; Sommerer K; Häussermann S; Mariotti F
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):269-280. PubMed ID: 29989511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthma.
    Harrison LI; Kurup S; Chen LZ; Ekholm BP; Wighton TG; Shapiro GG
    Eur J Clin Pharmacol; 2002 Jun; 58(3):191-5. PubMed ID: 12107605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.
    Craparo EF; Di Gioia S; Trapani A; Cellamare S; Belgiovine G; Mandracchia D; Giammona G; Cavallaro G; Conese M
    Int J Pharm; 2016 Aug; 510(1):263-70. PubMed ID: 27326484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
    Zheng J; Baldi S; Zhao L; Li H; Lee KH; Singh D; Papi A; Grapin F; Guasconi A; Georges G
    Respir Res; 2021 Mar; 22(1):90. PubMed ID: 33757520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.